$40M 11.4%Beat EPS +117.6%
Total revenue, Q4 '24 (USD).

Did RxSight Beat Earnings?

RxSight (RXST) reported Q4 '24 revenue of $40M, with reported EPS of $0.03. That topped the $-0.17 analyst estimate by 117.6% — an earnings beat.

AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — RxSight’s job postings, web traffic, and employee business outlook. See the full RXST stock analysis or the earnings calendar for upcoming reports.

RxSight Quarterly Financial Trends (USD)

MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Revenue45M40M38M34M30M33M31M34M
Gross margin55.5%71.6%74.8%74.9%79.9%77.5%76.1%76.7%
Operating margin-20.3%-21.5%-28.2%-41.6%-40.1%-34.8%-57.7%-40.8%
Net income-6.3M-5.9M-8.2M-12M-9.8M-9.2M-16M-12M
Net margin-14.0%-14.8%-21.6%-35.0%-32.4%-28.1%-51.4%-35.9%
EPS$0.03

RxSight Earnings Trend Analysis

Over the eight quarters from Q3 '24 to Q2 '26, RxSight’s quarterly revenue moved from $45M to $34M. Net margin compressed from -14% to -35.9%, against a 76.7% gross margin in the most recent quarter — a read on whether revenue growth is translating into profit. RxSight has beaten Wall Street EPS estimates in 1 of its last 1 reported quarters.

When Is RxSight’s Next Earnings Date?

RxSight reports earnings on a quarterly schedule. Its most recent report covered Q4 '24. For the confirmed upcoming date — and every other company reporting soon — see the RXST earnings calendar.

Frequently Asked Questions: RxSight Earnings

RxSight's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.

RxSight reported Q4 '24 EPS of $0.03 on revenue of $40M. RxSight beat estimates, reporting $0.03 vs. the $-0.17 estimate.

RxSight reported Q4 '24 revenue of $40M.

Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the RXST AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.